Diabetes Care Devices Market

1. Executive Summary
      1.1. Key Market Insights

2. Introduction
      2.1. Study Objectives
      2.2. Market Definition
               2.2.1. Market Covered
               2.2.2. Geographical Coverage
               2.2.3. Study Years & Currency
      2.3. Market Stakeholders
      2.4. Key Questions this Study will Answer
      2.5. GMI Research’s Approach & Methodology
               2.5.1. Research Data
               2.5.2. Primary Data
               2.5.3. Demand Side and Supply Side Analysis
               2.5.4. Market Size Estimation
               2.5.5. Research Assumptions

3. Global Diabetes Care Devices Market- Overview
      3.1. Introduction `
      3.2. Market Segmentation
      3.3. Value Chain Analysis
      3.4. Drivers
      3.5. Restraints
      3.6. Trends

4. Global Diabetes Care Devices Market Revenue Forecast till 2030

5. Global Diabetes Care Devices Market by Product Type Revenue Forecast till 2030

6. Global Diabetes Care Devices market by Product Type
      6.1. Blood Glucose Monitoring Device
      6.2. Insulin Delivery Device

7. Global Diabetes Care Devices market by End-User
      7.1. Hospitals
      7.2. Homecare Setting
      7.3. Others

8. Global Diabetes Care Devices market by Region
      8.1. North America Diabetes Care Devices Market Revenue Forecast till 2030
      (Option 1: As a part of the free 25% customization)
               8.1.1. North America Diabetes Care Devices Market by Product Type
                           8.1.1.1. Blood Glucose Monitoring Devices
                           8.1.1.2. Insulin Delivery Devices
               8.1.2. North America Diabetes Care Devices Market by End User
                           8.1.2.1. Hospitals
                           8.1.2.2. Homecare Setting
                           8.1.2.3. Others
      8.2. Europe Diabetes Care Devices Market Revenue Forecast till 2030
      (Option 2: As a part of the free 25% customization)
               8.2.1. Europe Diabetes Care Devices Market by Product Type
                           8.2.1.1. Blood Glucose Monitoring Devices
                           8.2.1.2. Insulin Delivery Devices
               8.2.2. Europe Diabetes Care Devices Market by End User
                           8.2.2.1. Hospitals
                           8.2.2.2. Homecare Setting
                           8.2.2.3. Others
      8.3. Asia-Pacific Automated Endoscopic Reprocessing Revenue Forecast till 2030
      (Option 3: As a part of the free 25% customization)
               8.3.1. Asia-Pacific Diabetes Care Devices Market by Product Type
                           8.3.1.1. Blood Glucose Monitoring Devices
                           8.3.1.2. Insulin Delivery Devices
               8.3.2. Asia-Pacific Diabetes Care Devices Market by End User
                           8.3.2.1. Hospitals
                           8.3.2.2. Homecare Setting
                           8.3.2.3. Others
      8.4. Rest of the World Diabetes Care Devices Market Revenue Forecast till 2030
      (Option 4: As a part of the free 25% customization)
               8.4.1. Rest of the World Diabetes Care Devices Market by Product Type
                           8.4.1.1. Blood Glucose Monitoring Devices
                           8.4.1.2. Insulin Delivery Devices
               8.4.2. Rest of the World Diabetes Care Devices Market by End User
                           8.4.2.1. Hospitals
                           8.4.2.2. Homecare Setting
                           8.4.2.3. Others

9. Competitive Landscape
      9.1. Industry Attractiveness
      9.2. Porter 5 Analysis
      9.3. Major players and their key strategies
      9.4. Company Share Analysis

10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
      10.1. Abbott Laboratories
               10.1.1. Company Overview
               10.1.2. Key Executives
               10.1.3. Footprint & Employee Strength
               10.1.4. Product Offerings
               10.1.5. Financials
               10.1.6. Key Company Developments
      10.2. Medtronic plc
               10.2.1. Company Overview
               10.2.2. Key Executives
               10.2.3. Footprint & Employee Strength
               10.2.4. Product Offerings
               10.2.5. Financials
               10.2.6. Key Company Developments
      10.3. Bayer HealthCare AG
               10.3.1. Company Overview
               10.3.2. Key Executives
               10.3.3. Footprint & Employee Strength
               10.3.4. Product Offerings
               10.3.5. Financials
               10.3.6. Key Company Developments
      10.4. F. Hoffmann-La Roche Ltd
               10.4.1. Company Overview
               10.4.2. Key Executives
               10.4.3. Footprint & Employee Strength
               10.4.4. Product Offerings
               10.4.5. Financials
               10.4.6. Key Company Developments
      10.5. Glaxosmithkline Plc
               10.5.1. Company Overview
               10.5.2. Key Executives
               10.5.3. Footprint & Employee Strength
               10.5.4. Product Offerings
               10.5.5. Financials
               10.5.6. Key Company Developments
      10.6. Johnson & Johnson
               10.6.1. Company Overview
               10.6.2. Key Executives
               10.6.3. Footprint & Employee Strength
               10.6.4. Product Offerings
               10.6.5. Financials
               10.6.6. Key Company Developments
      10.7. Becton, Dickinson and Company
               10.7.1. Company Overview
               10.7.2. Key Executives
               10.7.3. Footprint & Employee Strength
               10.7.4. Product Offerings
               10.7.5. Financials
               10.7.6. Key Company Developments
      10.8. Terumo Corporation
               10.8.1. Company Overview
               10.8.2. Key Executives
               10.8.3. Footprint & Employee Strength
               10.8.4. Product Offerings
               10.8.5. Financials
               10.8.6. Key Company Developments
      10.9. Dexcom, Inc.
               10.9.1. Company Overview
               10.9.2. Key Executives
               10.9.3. Footprint & Employee Strength
               10.9.4. Product Offerings
               10.9.5. Financials
               10.9.6. Key Company Developments
      10.10. Sanofi
               10.10.1. Company Overview
               10.10.2. Key Executives
               10.10.3. Footprint & Employee Strength
               10.10.4. Product Offerings
               10.10.5. Financials
               10.10.6. Key Company Developments

11. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.